WASHINGTON, D.C. β The Pan American Health Organization (PAHO) announced on May 12, 2026, a historic agreement with CSL Seqirus to reserve a portion of pandemic influenza vaccine production for countries in Latin America and the Caribbean. The deal aims to ensure equitable access to vaccines during future influenza pandemics.
Under the agreement, CSL Seqirus will allocate a dedicated share of its manufacturing capacity to produce vaccines for PAHO member states. This initiative is part of PAHO's broader strategy to strengthen pandemic preparedness and response in the region.
PAHO Director Dr. Jarbas Barbosa emphasized the importance of regional cooperation in health security. The agreement builds on lessons learned from the COVID-19 pandemic, which highlighted disparities in vaccine access between high-income and low-income countries.
CSL Seqirus, a global leader in influenza vaccine production, will work with PAHO to ensure timely delivery and distribution of vaccines. The specific terms of the reservation, including volumes and pricing, were not disclosed.
This partnership is expected to benefit millions of people across the region by reducing the risk of severe illness and death during future influenza outbreaks. PAHO continues to advocate for sustainable financing and technology transfer to bolster local vaccine production capabilities.
